Factor Model (net -1.0)
Factor Model
net -1.0 2.6 / 10$300M revenue headwind coming, but pivoting to core care
Watch: Track 2026 H1 results closely. The company expects only 40% of annual EBITDA in the first half, which means a dramatic back-half recovery is baked into guidance — miss that and the narrative inverts fast.
Accendra Health grew revenue 3% in 2025 to $2.8B but faces a cliff: a major commercial payer exit will slice $300M from top line in 2026. The company is shedding non-core assets to focus on home-based care brands Byram and Apria — a structural shift that management believes positions the business better long-term. Q4 EBITDA fell 12% year-over-year to $90M, signaling momentum weakening before the payer loss hits.
This isn't a typical slowdown — it's a forced restructuring into a core business that's presumably higher-margin but smaller. Management is betting that losing $300M in revenue (roughly 11% of total) while focusing on home care actually improves profitability, but the near-term math is brutal: 2026 revenue is guided to $2.55–$2.65B (down 9–10%) with EBITDA falling to $335–$355M (down 11–13%). If that pivot doesn't deliver margin accretion or new growth, this is a value destruction story.
Evidence
Fundamentals & Data ▾
Recent transactions
Get alerted when ACH changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.